Alphabet Inc

GV 2019 GP, LLC sells entire 147,552-share stake in LIFE for $3.5M at $23.45 avg, now holds 0 shares

GV 2019 GP, LLC, a 10% owner, executed 3 separate sales totaling 147,552 shares for $3,459,808.76, liquidating its entire position to zero shares. The sales occurred on 2026-05-14 and 2026-05-15 at prices ranging from $23.01 to $24.27, achieving a blended average price of $23.45—notably above the current price of $20.72. Ethos Technologies carries significant operational strain: net income of $-166,391,000.00 against revenue of $193,099,000.00, meaning the company is burning substantial cash despite 52.0% annual revenue growth. The complete exit by a 10% stakeholder during a period of heavy losses warrants investor attention, particularly given the asymmetry between the company's growth trajectory and its profitability crisis.

GV 2017 GP sells 1,845,308 shares at $19.00 for $35,060,852 after LIFE's recent listing

GV 2017 GP, a 10% owner, executed 2 separate sales totaling 1,845,308 shares for $35,060,852.00 on 2026-01-30 at $19.00 per share, reducing its holdings by 36.6% to 3,198,249 shares post-transaction. The transaction occurred only 2 trading days after Ethos Technologies Inc. (LIFE) completed its initial public listing, with shares trading at $15.05 current price as of the filing date. The sales price of $19.00 represents a 26.2% premium to the current market price, suggesting the insider executed sales at materially higher valuations during the immediate post-listing window. As a derivative-conversion transaction per Form 4 Table II, the reported Table I holdings do not represent the insider's complete position; investors should examine derivative holdings separately before drawing conclusions about total stake reduction.

10% Owner GV 2021 GP buys 1,500,000 shares at $3.30 in unprofitable biotech PRME; cluster of 3 other insiders buying within 14 days.

GV 2021 GP, a 10% shareholder, purchased 1,500,000 shares at $3.30 on 2025-08-01, expanding its stake by 85.1% to 3,262,440 shares (3.26M shares), a substantial commitment of $4,950,000.00 ($5.0M) in a company with a market cap of $573,756,763.98 ($573.8M). The company is unprofitable, reporting a net income of $-51,890,000.00 ($-51.9M) on quarterly revenue of $1,454,000.00 ($1.5M), indicating early-stage development with significant cash burn. The timing of this purchase aligns with a cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated alignment among company stakeholders on near-term value despite the company's loss position. The current price of $4.37 reflects a 30-day gain of +40.5% and a 90-day gain of +207.8%, though it remains -22.1% below the 52-week high of $5.61.